血小板凝集デバイスの世界市場：装置、試薬、消耗品、付属品...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.4.1 Assumptions

3 Executive Summary (Page No. – 27)
3.1 Introduction
3.2 Current Market Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 31)
4.1 Global Platelet Aggregation Devices Market, 2015–2020
4.2 Global Platelet Aggregation Devices Market, By Region (2015–2020)
4.3 Platelet Aggregation Devices Market, By Product (2015)
4.4 Global Market, By Application (2015–2020)
4.5 Global Market, By End User (2015–2020)

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Key Market Drivers
5.3.1.1 Rising Incidence of Target Diseases
5.3.1.2 Rapid Growth in the Geriatric Population Across the Globe
5.3.1.3 Technological Advancements in Platelet Aggregometers
5.3.1.4 Increasing Number of Industry-Academia Collaborations and Clinical Studies
5.3.2 Key Market Restraints
5.3.2.1 Procedural Limitations
5.3.2.2 Unfavorable Healthcare Reforms in the U.S.
5.3.2.3 Dearth of Well-Trained, Skilled, and Experienced Professionals
5.3.3 Key Market Opportunities
5.3.3.1 Emerging Markets
5.3.3.2 Advent of Point-Of-Care & Miniaturized Platelet Aggregometers
5.3.4 Key Market Challenges
5.3.4.1 Stringent Regulatory Policies
5.3.4.2 Limited Medical Reimbursements

6 Platelet Aggregation Devices Market, By Product (Page No. – 48)
6.1 Introduction
6.2 Systems
6.3 Reagents
6.4 Consumables and Accessories

7 Platelet Aggregation Devices Market, By Application (Page No. – 53)
7.1 Introduction
7.2 Clinical Applications
7.2.1 Cardiovascular Applications
7.2.2 Orthopedic Applications
7.2.3 Other Clinical Applications
7.3 Research Applications

8 Platelet Aggregation Devices Market, By End User (Page No. – 62)
8.1 Introduction
8.2 Standalone Hospitals
8.3 Diagnostic Laboratories
8.4 Research and Academic Institutes
8.5 Other End Users

9 Platelet Aggregation Devices Market, By Region (Page No. – 70)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 102)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.4 Recent Developments
10.4.1 New Product Launches and Product Enhancements
10.4.2 Acquisitions and Divestments
10.4.3 Agreements, Partnerships, and Collaborations
10.4.4 Geographical Expansions
10.4.5 Other Developments

11 Company Profiles (Page No. – 111)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Introduction
11.1.1 Geographic Revenue Mix
11.1.2 Strategic Benchmarking
11.1.2.1 Product Development and Commercialization
11.2 F. Hoffman-La Roche Ltd.
11.3 Haemonetics Corporation
11.4 Sysmex Corporation
11.5 Siemens AG
11.6 Accriva Diagnostics
11.7 Helena Laboratories Corporation
11.8 Bio/Data Corporation
11.9 Sentinel Ch. S.P.A.
11.10 TEM Group
11.11 Aggredyne, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 130)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports